Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan · Delayed Price · Currency is TWD 30.00
+0.10 (0.33%)
May 29, 2026, 1:24 PM CST
TPEX:4111 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,795 | 1,762 | 1,584 | 1,519 | 1,544 | 1,316 | |
Market Cap Growth | 2.44% | 11.23% | 4.32% | -1.66% | 17.32% | -3.55% |
Enterprise Value | 1,396 | 1,366 | 1,313 | 1,268 | 1,425 | 1,261 |
Last Close Price | 30.00 | 29.45 | 25.69 | 23.73 | 23.07 | 18.87 |
PE Ratio | 10.00 | 10.73 | 14.32 | 22.11 | 10.03 | 16.30 |
PS Ratio | 1.27 | 1.28 | 1.36 | 1.43 | 1.35 | 1.29 |
PB Ratio | 1.25 | 1.28 | 1.24 | 1.25 | 1.26 | 1.20 |
P/TBV Ratio | 1.25 | 1.28 | 1.24 | 1.25 | 1.26 | 1.20 |
P/FCF Ratio | 10.51 | 9.75 | 12.28 | - | 14.10 | - |
P/OCF Ratio | 7.58 | 6.42 | 7.43 | 20.38 | 7.19 | 9.45 |
EV/Sales Ratio | 0.99 | 0.99 | 1.13 | 1.20 | 1.25 | 1.23 |
EV/EBITDA Ratio | 4.90 | 4.99 | 7.95 | 10.29 | 6.50 | 6.61 |
EV/EBIT Ratio | 6.53 | 6.85 | 13.27 | 20.71 | 9.26 | 10.60 |
EV/FCF Ratio | 8.17 | 7.56 | 10.18 | - | 13.01 | - |
Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.10 | 0.11 | 0.13 |
Debt / EBITDA Ratio | 0.07 | 0.09 | 0.16 | 1.00 | 0.57 | 0.73 |
Debt / FCF Ratio | 0.12 | 0.13 | 0.21 | - | 1.17 | - |
Net Debt / Equity Ratio | -0.28 | -0.30 | -0.24 | -0.21 | -0.27 | -0.10 |
Net Debt / EBITDA Ratio | -1.39 | -1.53 | -1.87 | -2.10 | -1.50 | -0.57 |
Net Debt / FCF Ratio | -2.33 | -2.32 | -2.40 | 9.57 | -2.99 | 0.86 |
Asset Turnover | 0.76 | 0.75 | 0.66 | 0.60 | 0.66 | 0.65 |
Inventory Turnover | 8.07 | 8.32 | 8.26 | 7.63 | 7.61 | 7.58 |
Quick Ratio | 1.92 | 1.74 | 1.83 | 1.57 | 1.54 | 1.20 |
Current Ratio | 2.26 | 2.01 | 2.11 | 1.78 | 1.78 | 1.46 |
Return on Equity (ROE) | 13.06% | 12.37% | 8.87% | 5.63% | 15.44% | 9.90% |
Return on Assets (ROA) | 7.17% | 6.76% | 3.52% | 2.15% | 5.56% | 4.73% |
Return on Invested Capital (ROIC) | 17.00% | 16.44% | 8.25% | 5.19% | 16.31% | 11.15% |
Return on Capital Employed (ROCE) | 14.00% | 13.50% | 7.20% | 4.70% | 11.70% | 9.80% |
Earnings Yield | 10.00% | 9.32% | 6.98% | 4.52% | 9.97% | 6.13% |
FCF Yield | 9.52% | 10.26% | 8.14% | -1.78% | 7.09% | -9.54% |
Dividend Yield | 3.17% | - | 3.71% | 4.01% | 4.95% | 5.05% |
Payout Ratio | 31.76% | 34.69% | 51.51% | 99.57% | 37.00% | 70.57% |
Buyback Yield / Dilution | - | -0.40% | -0.12% | 0.16% | -0.06% | -0.10% |
Total Shareholder Return | 3.17% | -0.40% | 3.59% | 4.17% | 4.89% | 4.95% |